Abivax S.A.
obefazimod
ulcerative colitis
Countdown
177days
Approval decision · ~ Dec 31, 2026 estimated
What's at stake
A final FDA approval decision on obefazimod for ulcerative colitis is expected ~ Dec 31, 2026.
Primary source
· SEC 6-K
verified 12h ago
“Based on current operating assumptions, the Registrant intends to submit a New Drug Application to the U.S. Food and Drug Administration in late fourth quarter of 2026.”